Scher HI - Search Results

1

Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha.

Buchanan G, Ricciardelli C, Harris JM, Prescott J, Yu ZC, Jia L, Butler LM, Marshall VR, Scher HI, Gerald WL, Coetzee GA, Tilley WD. Buchanan G, et al. Among authors: scher hi. Cancer Res. 2007 Oct 15;67(20):10087-96. doi: 10.1158/0008-5472.CAN-07-1646. Cancer Res. 2007. PMID: 17942943

2

Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications.

Ghossein RA, Scher HI, Gerald WL, Kelly WK, Curley T, Amsterdam A, Zhang ZF, Rosai J. Ghossein RA, et al. Among authors: scher hi. J Clin Oncol. 1995 May;13(5):1195-200. doi: 10.1200/JCO.1995.13.5.1195. J Clin Oncol. 1995. PMID: 7537803

3

Ligand responsiveness in human prostate cancer: structural analysis of mutant androgen receptors from LNCaP and CWR22 tumors.

McDonald S, Brive L, Agus DB, Scher HI, Ely KR. McDonald S, et al. Among authors: scher hi. Cancer Res. 2000 May 1;60(9):2317-22. Cancer Res. 2000. PMID: 10811100

4

Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone.

Drobnjak M, Osman I, Scher HI, Fazzari M, Cordon-Cardo C. Drobnjak M, et al. Among authors: scher hi. Clin Cancer Res. 2000 May;6(5):1891-5. Clin Cancer Res. 2000. PMID: 10815912

5

Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.

Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C, Thaler HT, Rifkind RA, Marks PA, Richon VM. Butler LM, et al. Among authors: scher hi. Cancer Res. 2000 Sep 15;60(18):5165-70. Cancer Res. 2000. PMID: 11016644

6

Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1.

Amler LC, Agus DB, LeDuc C, Sapinoso ML, Fox WD, Kern S, Lee D, Wang V, Leysens M, Higgins B, Martin J, Gerald W, Dracopoli N, Cordon-Cardo C, Scher HI, Hampton GM. Amler LC, et al. Among authors: scher hi. Cancer Res. 2000 Nov 1;60(21):6134-41. Cancer Res. 2000. PMID: 11085537

7

Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase.

Butler LM, Webb Y, Agus DB, Higgins B, Tolentino TR, Kutko MC, LaQuaglia MP, Drobnjak M, Cordon-Cardo C, Scher HI, Breslow R, Richon VM, Rifkind RA, Marks PA. Butler LM, et al. Among authors: scher hi. Clin Cancer Res. 2001 Apr;7(4):962-70. Clin Cancer Res. 2001. PMID: 11309347

8

Collocation of androgen receptor gene mutations in prostate cancer.

Buchanan G, Greenberg NM, Scher HI, Harris JM, Marshall VR, Tilley WD. Buchanan G, et al. Among authors: scher hi. Clin Cancer Res. 2001 May;7(5):1273-81. Clin Cancer Res. 2001. PMID: 11350894

9

17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts.

Solit DB, Zheng FF, Drobnjak M, Münster PN, Higgins B, Verbel D, Heller G, Tong W, Cordon-Cardo C, Agus DB, Scher HI, Rosen N. Solit DB, et al. Among authors: scher hi. Clin Cancer Res. 2002 May;8(5):986-93. Clin Cancer Res. 2002. PMID: 12006510

10

Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease.

LaTulippe E, Satagopan J, Smith A, Scher H, Scardino P, Reuter V, Gerald WL. LaTulippe E, et al. Cancer Res. 2002 Aug 1;62(15):4499-506. Cancer Res. 2002. PMID: 12154061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

695 results

Search Page

Filters